MarketBeatSat, 06 Jun 2026 09:04:58 GMTBlack Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA PathBDTX+15.53%
Zacks Investment ResearchWed, 27 May 2026 16:21:12 GMTBDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh CatalystBDTX+15.53%
Zacks Investment ResearchWed, 27 May 2026 16:15:43 GMTBlack Diamond Stock Outlook After Q1 Beat and Cash RunwayBDTX+15.53%
Zacks Investment ResearchWed, 27 May 2026 16:11:08 GMTBDTX Silevertinib Data in EGFR NSCLC: What Investors Need to KnowBDTX+15.53%
Zacks Investment ResearchMon, 25 May 2026 15:55:30 GMTBDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study DataBDTX+15.53%
MarketBeatThu, 21 May 2026 23:09:20 GMTBlack Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 StudyBDTX+15.53%
Zacks Investment ResearchMon, 11 May 2026 16:51:22 GMTBDTX Shares Gain 11% in a Week: Here's What You Should KnowBDTX+15.53%
Zacks Investment ResearchTue, 28 Apr 2026 12:06:08 GMTImplied Volatility Surging for Black Diamond Therapeutics Stock OptionsBDTX+15.53%
Zacks Investment ResearchThu, 23 Apr 2026 16:30:37 GMTBDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go RightBDTX+15.53%
Zacks Investment ResearchThu, 23 Apr 2026 16:30:27 GMTBDTX and the CNS-Active EGFR Trend: Why C797S Is the PrizeBDTX+15.53%
Zacks Investment ResearchThu, 23 Apr 2026 16:25:31 GMTBlack Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and RisksBDTX+15.53%
Zacks Investment ResearchWed, 15 Apr 2026 16:30:23 GMTWhy Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?BDTX+15.53%
Zacks Investment ResearchThu, 09 Apr 2026 17:26:05 GMTBDTX and Brain Metastases: Why CNS Activity Could Matter in 2026BDTX+15.53%
Zacks Investment ResearchThu, 09 Apr 2026 17:21:10 GMTBlack Diamond Stock: Weighing Catalysts vs. ConcentrationBDTX+15.53%
Zacks Investment ResearchThu, 09 Apr 2026 17:16:14 GMTBDTX: What Silevertinib Data Say About EGFR NSCLC UpsideBDTX+15.53%
